Marijuana

Hepatitis C

OMNI Medical Services, LLCPhase 2Dormant

CCC

53/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 38/ 100
Competitive Position: 95/ 100

Competitive context

7 Active assets in the Hepatitis C cohort.

Asset / Sponsor	Phase	Rating
Daclatasvir MTI University	Phase 4	A
Ribavirin Peking University People's Hospital	Phase 4	A
Sofosbuvir Peking University People's Hospital	Phase 4	A
Simeprevir University of Colorado, Denver	Phase 4	A
Pegylated Interferon Alpha2A Tanta University	Phase 4	A

View all 50 →

Same molecule, other indications

Marijuana is also rated in:

CannabisDormant

BB

Indicative ·

71 / 100

HIV NeuropathyDormant

BB

Indicative ·

65 / 100

Diabetic Peripheral Neuropathic PainDormant

B

Indicative ·

62 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.